We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
+9.43%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$336M
AUM Growth
+$14.4M
Cap. Flow
-$10M
Cap. Flow %
-2.98%
Top 10 Hldgs %
55.65%
Holding
52
New
7
Increased
17
Reduced
14
Closed
9

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$11.7M
2
CMCSA icon
Comcast
CMCSA
+$8.1M
3
GSK icon
GSK
GSK
+$6.99M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$5.45M
5
CG icon
Carlyle Group
CG
+$3.57M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$15.1M
2
VST icon
Vistra
VST
+$9.23M
3
BMY icon
Bristol-Myers Squibb
BMY
+$6.41M
4
VVV icon
Valvoline
VVV
+$5.5M
5
ARES icon
Ares Management
ARES
+$5.41M

Sector Composition

Rank Sector Weight
1 Financials 53.11%
2 Healthcare 15.91%
3 Real Estate 9.15%
4 Consumer Staples 5.81%
5 Consumer Discretionary 4.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXSL icon
1
Blackstone Secured Lending
BXSL
$5.41B
$27.7M 8.25%
1,240,000
+232,772
+23% +$5.45M
TSLX icon
2
Sixth Street Specialty
TSLX
$1.59B
$23.5M 6.99%
1,319,936
+96,186
+8% +$1.72M
VTRS icon
3
Viatris
VTRS
$20.1B
$22.5M 6.7%
2,020,469
+299,216
+17% +$3.13M
BBDC icon
4
Barings BDC
BBDC
$862M
$18M 5.36%
2,209,955
-165,045
-7% -$1.43M
RDN icon
5
Radian Group
RDN
$5.14B
$17.5M 5.22%
920,000
+57,500
+7% +$1.12M
CCI icon
6
Crown Castle
CCI
$32.7B
$17.5M 5.22%
129,237
+86,737
+204% +$11.7M
SNY icon
7
Sanofi
SNY
$104B
$17M 5.05%
350,000
+50,000
+17% +$2.19M
KKR icon
8
KKR & Co
KKR
$89.2B
$15.6M 4.63%
335,000
-15,000
-4% -$731K
EQH icon
9
Equitable Holdings
EQH
$13.1B
$14.9M 4.43%
518,602
-15,318
-3% -$453K
OWL icon
10
Blue Owl Capital
OWL
$6.39B
$12.7M 3.79%
1,201,918
+165,000
+16% +$1.74M
MPT
11
Medical Properties Trust
MPT
$2.89B
$11.8M 3.52%
1,060,000
+175,000
+20% +$2.03M
PNNT
12
Pennant Park Investment Corp
PNNT
$215M
$10.8M 3.21%
1,875,000
+36,320
+2% +$213K
LEN icon
13
Lennar Class A
LEN
$20.4B
$10.4M 3.1%
118,795
– –
ARES icon
14
Ares Management
ARES
$28.5B
$10.3M 3.06%
150,000
-75,000
-33% -$5.41M
SPB icon
15
Spectrum Brands
SPB
$2.04B
$9.14M 2.72%
150,000
+50,000
+50% +$2.52M
CMCSA icon
16
Comcast
CMCSA
$79.1B
$8.57M 2.55%
+245,000
New +$8.1M
GSK icon
17
GSK
GSK
$103B
$7.38M 2.2%
+210,000
New +$6.99M
MO icon
18
Altria Group
MO
$122B
$7.31M 2.18%
160,000
-115,000
-42% -$5.21M
VZ icon
19
Verizon
VZ
$194B
$6.89M 2.05%
175,000
+57,500
+49% +$2.17M
OBDC icon
20
Blue Owl Capital
OBDC
$5.35B
$5.78M 1.72%
500,000
+190,000
+61% +$2.28M
BMY icon
21
Bristol-Myers Squibb
BMY
$127B
$5.76M 1.71%
80,000
-85,000
-52% -$6.41M
FSK icon
22
FS KKR Capital
FSK
$2.98B
$5.74M 1.71%
328,053
-46,947
-13% -$873K
VST icon
23
Vistra
VST
$55.1B
$5.37M 1.6%
231,351
-398,692
-63% -$9.23M
TRIN icon
24
Trinity Capital
TRIN
$1.55B
$4.84M 1.44%
442,427
-293,141
-40% -$3.41M
VST icon
25
CALL
Vistra
VST
$55.1B
$4.64M 1.38%
200,000
– –
1
2 3

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return

Callodine Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Callodine Capital Management held 52 positions worth $336M, up 4.5% from $322M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Callodine Capital Management's Q4 2022 filing shows 7 new, 17 increased, 14 reduced and 9 closed positions. Its largest new stake was Comcast: 245,000 shares worth $8.57M. The largest sale was Merck, an estimated $15.1M.

By sector, the portfolio is most concentrated in Financials at 53% of assets, down from 54% a quarter earlier, followed by Healthcare and Real Estate.

  • Callodine Capital Management's largest Q4 2022 buy was Comcast: 245,000 shares worth $8.57M.
  • Callodine Capital Management added most to Crown Castle in Q4 2022, an estimated $11.7M increase.
  • Callodine Capital Management's biggest Q4 2022 reduction was Vistra, cutting an estimated $9.23M.
  • Callodine Capital Management fully exited Merck in Q4 2022, selling an estimated $15.1M.
  • Callodine Capital Management's ten largest holdings make up 56% of its $336M portfolio in Q4 2022.
  • Callodine Capital Management opened 7 new positions and closed 9 in Q4 2022.
  • Callodine Capital Management's portfolio value rose 4.5% quarter-over-quarter to $336M.

Based on Callodine Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.